Live news related to DBV TECHNOLOGIES stock (FR0010417345): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on DBV TECHNOLOGIES mainly cover analyst notes, earnings publications et M&A activity. The stock trades at €2,38 on Euronext Paris, up 0,25% at the last update. This page lists the articles published on DBV TECHNOLOGIES stock to track the share price, company announcements and any item likely to influence market perception.
The French biotech continues its slide during the session, moving against the trend of an already heavily declining SBF 120. The stock is sinking belo…
The French biotech company falls mid-morning, moving against a slightly bullish Paris market. The stock is trailing at the bottom of the broad index, …
DBV Technologies has filed a prospectus with the SEC for an at-the-market (ATM) offering, allowing the French biotech to raise up to $150 million thro…
The French biotech company is trending downwards during the session, contrary to a nearly stable SBF 120. The stock is among the largest declines of t…
The French biotech significantly recovers mid-day, going against the grain of a heavily penalized Paris market due to geopolitical tensions. The stock…
The French biotech company falls during the session, going against the grain of a significantly bullish SBF 120. The stock slips to the bottom of the …
The French biotech company regains momentum in mid-morning trading, bucking the trend of a declining SBF 120. The stock is among the top gainers of th…
The French biotech company sees a midday drop, contrary to a slightly positive SBF 120. The stock is among the largest declines in the broad index, er…
DBV Technologies has announced the completion of its extensive discussions with the Food and Drug Administration (FDA) regarding the submission of a B…
In mid-morning trading, the French biotech company regains ground, moving against the trend of a slightly declining SBF 120. The stock is among the la…
